QDEL: QuidelOrtho Corporation Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 2,759.54
Enterprise Value ($M) 5,374.34
Book Value ($M) 3,009.50
Book Value / Share 44.75
Price / Book 0.92
NCAV ($M) -2,220.20
NCAV / Share -33.01
Price / NCAV -1.24

Profitability (mra)
Return on Invested Capital (ROIC) -0.34
Return on Assets (ROA) -0.24
Return on Equity (ROE) -0.40

Liquidity (mrq)
Quick Ratio 0.69
Current Ratio 1.22

Balance Sheet (mrq) ($M)
Current Assets 1,218.90
Assets 6,448.60
Liabilities 3,439.10
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,782.90
Operating Income 45.80
Net Income -2,027.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 83.00
Cash from Investing -149.90
Cash from Financing 48.80

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A T. Rowe Price Investment Management, Inc.
02-13 13G/A Rubric Capital Management LP
02-07 13G Invesco Ltd.
02-05 13G/A BlackRock, Inc.
12-06 13G/A Vanguard Group Inc 10.13 12.67
11-21 13D/A Carlyle Group Inc. 0.00 -100.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 264,785 665,954 39.76
2025-02-20 162,092 461,198 35.15
2025-02-19 177,692 616,996 28.80
2025-02-18 181,785 650,738 27.94

(click for more detail)

Similar Companies
PRTA – Prothena Corporation plc PTCT – PTC Therapeutics, Inc.
PYXS – Pyxis Oncology, Inc. QNCX – Quince Therapeutics, Inc.
QURE – uniQure N.V.


Financial data and stock pages provided by
Fintel.io